Spleen and Liver 2-Dimensional Shear Wave Elastography for Clinically Significant Portal Hypertension
Clinical Gastroenterology and Hepatology · 2026-09
DOI: 10.1016/j.cgh.2026.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Christian Sebesta und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic La…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung, Bundesministerium für Digitalisierung und Wirtschaftsstandort, Ludwig Boltzmann Gesellschaft.
Abstract (Originalsprache)
BACKGROUND & AIMS: Liver (LSM) and spleen (SSM) stiffness measurements correlate with hepatic venous pressure gradient (HVPG), the reference standard for defining clinically significant portal hypertension (CSPH; ie, HVPG ≥10 mm Hg). LSM, SSM, and derived scores have been proposed for noninvasive CSPH risk assessment. METHODS: Patients with compensated advanced chronic liver disease undergoing same-day HVPG, SuperSonic Imagine (SSI)-LSM, and SSI-SSM were prospectively included. Reliable SSI-LSM and SSI-SSM were defined by interquartile range/median ≤30%. SSI-LSM, SSI-SSM, and derived Baveno VII rules, Anticipate-SSI, liver-platelet-spleen (LPS)-SSI, and the newly developed SSI-4PH (LSM and SSM, platelet count, body mass index) model were evaluated in a derivation cohort (DeCo) and an external validation cohort (VaCo). RESULTS: The DeCo comprised 220 patients, paired reliable SSI-LSM and SSI-SSM measurements were available in 118 patients (53.6%) including 74.6% with CSPH. The VaCo comprised 86 eligible patients, of whom 73 (84.9%) had paired reliable measurements including 43.8% with CSPH. In reliable paired analyses, the areas under the receiver operating characteristic curve for CSPH detection in the DeCo were 0.84 for Anticipate-SSI, 0.87 for LPS-SSI, and 0.90 for SSI-4PH; the corresponding areas under the receiver operating characteristic curve in the VaCo were 0.78, 0.77, and 0.73. At the fixed ≥75% predicted risk threshold, the specificity of SSI-4PH was 83.3% in the DeCo and 87.8% in the VaCo. CONCLUSIONS: Reliable SSI-LSM and SSI-SSM provide robust noninvasive assessment of CSPH risk; however, the requirement of reliable (interquartile range/median ≤30%) paired measurements may limit applicability. Combined SSI-LSM- and SSM-based rules and multivariable models reduced the gray zone, and the SSI-4PH yielded a favorable decision-curve utility for CSPH risk assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine…
- Department of Visceral Surgery and Medicine (UVCM), Bern University Hospital, Bern, Switzerland.
- Department of Internal Medicine B, University of Münster, Münster, Germany.
- Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Departament de Medicina i Ciències de la Salut, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBEREHD (Centro de Investigaci…
- Hepatology Department, Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.
- Université Paris Cité, Centre de Recherche sur L'Inflammation, Paris, France; Department of Hepato- and Gastroenterology, Tours University Hospital, Tours, France.
Förderung
- Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
- Bundesministerium für Digitalisierung und Wirtschaftsstandort
- Ludwig Boltzmann Gesellschaft
- Boehringer Ingelheim
- Christian Doppler Forschungsgesellschaft
Zitieren
APA
Sebesta, C., Jachs, M., Hartl, L., Schwarz, M., Balcar, L., Hofer, B. S., Dominik, N., Kramer, G., Thöne, P., Berzigotti, A., Cabello Calleja, J., García-Pagán, J. C., Morosan, I., Sebastian McCoy, M., Procopeț, B., Ștefănescu, H., Trebicka, J., Uschner, F. E., Elkrief, L., …, & Bauer, D. J. M. (2026). Spleen and Liver 2-Dimensional Shear Wave Elastography for Clinically Significant Portal Hypertension. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.09.002
Vancouver
Sebesta C, Jachs M, Hartl L, Schwarz M, Balcar L, Hofer BS, et al. Spleen and Liver 2-Dimensional Shear Wave Elastography for Clinically Significant Portal Hypertension. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.09.002
BibTeX
@article{Sebesta2026,
author = {Sebesta, Christian and Jachs, Mathias and Hartl, Lukas and Schwarz, Michael and Balcar, Lorenz and Hofer, Benedikt S and Dominik, Nina and Kramer, Georg and Thöne, Paul and Berzigotti, Annalisa and Cabello Calleja, Josune and García-Pagán, Juan Carlos and Morosan, Ioana and Sebastian McCoy, Martin and Procopeț, Bogdan and Ștefănescu, Horia and Trebicka, Jonel and Uschner, Frank Erhard and Elkrief, Laure and Rautou, Pierre-Emmanuel and Scheiner, Bernhard and Stättermayer, Albert F and Simbrunner, Benedikt and Schöchtner, Till and Haimberger, Friedrich and Balutsch, Nicolas and Trauner, Michael and Mandorfer, Mattias and Reiberger, Thomas and Bauer, David J M},
title = {Spleen and Liver 2-Dimensional Shear Wave Elastography for Clinically Significant Portal Hypertension},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.09.002}
}
EUVIMED